T2 Biosystems T2SARS-CoV-2 panel proved effective with global rise in variants of the SARS-CoV-2 virus
On Jan. 11, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detects…
On Jan. 11, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detects…
On Jan. 11, 2021, Moderna announced that it was expanding its pipeline of innovative vaccines with three new…
On Jan. 11, 2021, AXIM Biotechnologies announced that it had released a preprint of its manuscript describing the…
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
On Jan. 8, 2021, the COVID-19 vaccine developed by Moderna has today been given regulatory approval for supply…
On Jan. 8, 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) announced it had accepted the recommendation…
On Jan. 8, 2021, BioNTech announced that it was in talks with the European Commission (EC) about an…
On Jan. 7, 2021, Twist Bioscience announced it would supply the U.S. Centers for Disease Control and Prevention…
On Jan. 7, 2021, Novavax announced that it had executed an Advance Purchase Agreement with the Commonwealth of…
On Jan. 6, 2021, the La Jolla Institute for Immunology announced data that suggest nearly all COVID-19 survivors…
On Jan. 6, 2021, Moderna announced that the European Commission had granted a conditional marketing authorization for COVID-19…
On Jan. 5, 2021, Illumina and Helix announced a collaboration to augment national surveillance infrastructure in the U.S….
On Jan. 4, 2021, a research partnership between scientists at Scripps Research and UC San Diego found the…
On Jan. 4, 2021, Moderna announced a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global…
On Jan. 4, 2021, Moderna announced that Israel’s Ministry of Health (MOH) had given authorization to import the…
On Jan. 4, 2021, Inovio Pharmaceuticals and Advaccine Biopharmaceuticals announced that they had entered into a collaboration and…
On Dec. 31, 2020, the World Health Organization (WHO) listed the Comirnaty COVID-19 mRNA vaccine for emergency use,…
On Dec. 31, 2020, Moderna confirmed it had entered into a supply agreement with the government of the…
On Dec. 31, 2020, CytoDyn announced a research manuscript submitted by Nicholas J. Agresti, M.D. had been accepted…
On Dec. 30, 2020, Moderna announced that they had reached an agreement to support formulation and fill-finish a…
On Dec. 30, 2020, the National Institutes of Health (NIH) announced that the investigational vaccine known as mRNA-1273…
On Dec. 30, 2020, Medigen Vaccine Biologics announced that it had obtained TFDA Phase 2 IND approval of…
On Dec. 30, 2020, Mateon Therapeutics announced that it had enrolled and treated its first sentinel Part 1…
On Dec. 29, 2020, the U.S. Department of Defense (DOD) announced that the Womack Army Medical Center was…
On Dec. 29, 2020, Moderna confirmed that the Company was engaged in discussions with the government of South…
On Dec. 29, 2020, University of Nebraska Medical Center (UNMC) and Nebraska Medicine announced participation in a clinical…
On Dec. 28, 2020, Serum Institute of India announced the launch of India’s first indigenously developed pneumococcal vaccine…
On Dec. 28, 2020, Novavax announced initiation of PREVENT-19, its pivotal Phase 3 study in the U.S. and…
On Dec. 24, 2020, Inovio Pharmaceuticals announced publication of peer-reviewed Phase 1 clinical data from the first cohort…
On Dec. 23, 2020, Moderna announced that Health Canada had authorized its vaccine against COVID-19 for the immunization…